Specialists from the Tokyo Institute of Medical Sciences are working on a coronavirus vaccine with lifelong immunity.

APA reports quoting Japan Times that scientists are continuing the experiment based on a vaccine against smallpox developed by British doctor Edward Jenner in the 18th century.

Experts intend to create a recombinant vaccine virus that has few side effects and does not require special methods of transportation and storage.

It was stated that the development of a lifelong vaccine could give the world an advantage in the fight against COVID-19.

Experiments on mice infected with the recombinant vaccine virus encoding the bird flu gene have shown high antibody levels that will last for more than 20 months.

Next year, Japanese drugmaker Nobelpharma will conduct Phase I and Phase II clinical trials of the Kohara vaccine.